CEO to lower drug price after controversy

06:42

CNBC’s Meg Tirrell and LSU Health Sciences Center’s Dr. Corey Hebert discuss Turing Pharmaceutical CEO Martin Shkreli’s decision to lower the price of prescription drug Daramprim after raising the price from $13.50 to $750 yesterday.